Tag: Cancer: Cervical
Age to Stop Cervical Cancer Screening Depends on Test Used
Negative HPV test, HPV-cytology co-test tied to low remaining lifetime cancer risk for unvaccinated
Minimally Invasive Sx May Up Mortality in Early Cervical Cancer
Two studies show increased mortality and reduced disease-free, overall survival versus open surgery
Positive HPV Status Tied to Better Cervical Cancer Prognosis
Five-year relative survival ratio better for hrHPV-positive cases than for hrHPV-negative cases
Catch-Up HPV Doses Effective to Age 21 Against Cervical Neoplasia
But catch-up doses not effective against CIN for women who initiated vaccination at 21 to 26 years
USPSTF Updates Guidance for Cervical Cancer Screening
Cytology recommended every three years from age 21; different screening options from age 30 to 65
HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis
Use of primary HPV testing results in significantly lower odds of CIN3+ compared with cytology testing
Good Evidence That HPV Vaccines Protect Against Cervical Precancer
High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years
Mortality Risk Persists for Cancer Tied to Prenatal DES Exposure
Women with DES-related clear-cell adenocarcinoma had 27-fold higher mortality at 10 to 34 years
Cervical Cancer Frequently Diagnosed After Age 65
Almost 20 percent of cervical cancer cases are diagnosed in women older than 65
Many Untreated CIN2 Lesions Regress Spontaneously
Regression of cervical intraepithelial neoplasia grade 2 lesions especially likely in younger women
